A phase 2 study of ARQ 501 in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Beta lapachone (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- Sponsors ArQule
- 20 Mar 2008 Status changed from in progress to completed, in accordance with clinicaltrials.gov.
- 05 Feb 2007 Status change from recruiting to in progress.
- 23 Jan 2007 Trial centres added.